Report

A Survey-Based Exploration of Biopharma's Shifting Landscape and the Crucial Role of Direct-to-Patient Trials

In the ever-changing landscape of clinical research, transformation is driven by forces of economic challenges,…

Blog

Embracing Virtual in Psychiatry Research

The field of clinical research has undergone a remarkable transformation in recent years, accelerated by…

Blog

Rare Disease Research: The Impact of Decentralized Trials

Authors: Jonathan Cotliar, MD and Suzanne Pendl, MD Collectively, rare diseases are not so rare.…

Report

New FDA Draft Guidance Shows That the Time for Decentralized Clinical Trials is Now

On May 1, 2023, the U.S. Food and Drug Administration (FDA) released an updated Draft Guidance on…

Blog

How Decentralized Trials Transform Patient Recruitment

Author: Erica Prowisor, Senior Vice President, Patient and Provider Networks, Science 37 In the dynamic…

Blog

Decentralized Clinical Trials: Why They Matter

Author: Darcy Forman, Chief Delivery Officer, Science 37 In the past few years, the clinical…

Blog

The Time for Decentralized Clinical Trials is Now

The FDA Draft Guidance on Decentralized Clinical Trials provides recommendations for clinical trial sponsors to…

Report

Transform Observational Studies with a Virtual Site

Are your observational or long-term follow-up studies facing challenges? Are keeping protocols open across multiple…

Case Study

Breakthrough Decentralized Respiratory Trial with Pulmonary Function Testing

A large biopharma company was conducting a Phase IV trial of an approved biologic to…

Webinar

Disrupting the Clinical Trial: When to Decentralize?

Learn more about agile technologies and industry standards that are needed to drive clinical trial…

Webinar

Virtual Sites - Are They the Future of RWE?

The adoption of virtual sites, that are powered by decentralized clinical trial tools, has increased…

Webinar

Let's Plan, Do, Check, and Act: Leading Diversity in Clinical Trials Through Effective Metrics

The Equity intention of the FDA is clear, the pharmaceutical industry must provide a Diversity…